David M. Knott’s Avadel Pharmaceuticals AVDL Stock Holding History

David M. Knott’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2.96M	Sell	301,864 -3,058	-1%	-$24.1K	1.07%	27
2021 Q2	$2.05M	Buy	304,922 +32,077	+12%	+$255K	0.73%	38
2021 Q1	$2.47M	Buy	272,845 +185,929	+214%	+$1.5M	1.06%	27
2020 Q4	$581K	Buy	+86,916	New	+$544K	0.26%	54
2018 Q1	–	Sell	-158,555	Closed	-$1.3M	–	108
2017 Q4	$1.3M	Hold	158,555	–	–	0.52%	21
2017 Q3	$1.67M	Buy	158,555 +32,092	+25%	+$306K	0.71%	15
2017 Q2	$1.4M	Buy	126,463 +26,876	+27%	+$270K	0.58%	16
2017 Q1	$964K	Hold	99,587	–	–	0.46%	21
2016 Q4	$1.03M	Hold	99,587	–	–	0.52%	18
2016 Q3	$1.24M	Hold	99,587	–	–	0.64%	14
2016 Q2	$1.07M	Hold	99,587	–	–	0.25%	31
2016 Q1	$1.1M	Hold	99,587	–	–	0.29%	34
2015 Q4	$1.22M	Buy	+99,587	New	+$1.55M	0.33%	35

Other funds holding AVDL

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

GJL

Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

David M. Knott's AVDL Position: Q3 2021 in Review

David M. Knott reduced its Avadel Pharmaceuticals (AVDL) stake by 1% in Q3 2021, selling an estimated $24.1K and leaving 301,864 shares worth $2.96M. The position accounts for 1.07% of the portfolio, ranked #27.

David M. Knott first reported a position in AVDL in Q4 2015 and has held it in 13 quarters since. 81 funds tracked by Wall St. Rank hold AVDL as of Q3 2021.

David M. Knott held 301,864 shares of Avadel Pharmaceuticals worth $2.96M as of Q3 2021.
David M. Knott sold 3,058 Avadel Pharmaceuticals shares in Q3 2021, an estimated $24.1K.
Avadel Pharmaceuticals made up 1.07% of David M. Knott's portfolio in Q3 2021, its #27 holding.
David M. Knott first reported a position in Avadel Pharmaceuticals in Q4 2015 and has held it in 13 quarters since.
81 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.